Arbe Robotics Ltd. (Nasdaq: ARBE) ("Arbe"), a global leader in next-generation 4D Imaging Radar Solutions, announced today third quarter 2021 financial results and provided a business update.
Kobi Marenko, Chief Executive Officer, said "We are excited to report a solid quarter of continued operational, technological, and strategic progress. Our successful business combination and presence on the NASDAQ market marks a significant milestone and helps to cement our leadership position ahead of what we see as an imminent, revolutionary change in the global automotive technology market. We look forward to demonstrating the value of our next-generation Imaging Radar and its importance to the future of the automotive industry. We are progressing and paving the road for the adoption of our technology and for the universal acceptance of our products."
Karine Pinto-Flomenboim, Chief Financial Officer, added, "We remain confident in the full range of our projections for growth, our financial performance, the expansion of our operational capabilities, the pace of progress in our research and development efforts, and the adoption of our technology and products by a range of important customers around the world."
Commercial Traction
Technology Leadership
Arbe's Third Quarter 2021 Financial Highlights
Outlook
Investor Event
Arbe will host an investor event (https://arberobotics.com/investorevent/) today at 10am Eastern Time, which will include commentary on its third quarter 2021 financial performance and Q&A. The presentation will be available on the Company's website following the event.
About Arbe
Arbe (Nasdaq: ARBE), a global leader in next-generation 4D Imaging Radar Chipset Solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems today while paving the way to full autonomous-driving. Arbe's imaging radar is 100 times more detailed than any other radar on the market and is a mandatory sensor for L2+ and higher autonomy. The company is empowering automakers, tier-1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm-changing perception. Arbe is a leader in the fast-growing automotive radar market that has an estimated projected total addressable market of $11 billion in 2025. Arbe is based in Tel Aviv, Israel, and has an office in the United States.
Use of Non-GAAP Financial Measures
This press release contains financial information calculated other than in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). The non-GAAP measures presented by the Company are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Company's financial results. Therefore, these measures should not be considered in isolation or as an alternative to net income, cash flows from operations or other measures of profitability, liquidity or performance under GAAP. Arbe's presentation of these measures may not be comparable to similarly-titled measures used by other companies. These non-GAAP financial measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in determining these non-GAAP financial measures and should be considered in addition to, and not as a substitute for, comparable GAAP measures. The non-GAAP measures used in this press release are Non-GAAP Net Loss and Adjusted EBITDA. The Company provides these non-GAAP financial measures because it believes that they present a measure of the Company's core business that management uses internally to evaluate the Company's ongoing performance. Reconciliations of these non-GAAP measures to the Company's Net Loss can be found immediately following the Consolidated Statements of Cash Flows included in this press release. In evaluating Arbe, undue reliance should not be placed on the non-GAAP financial information.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding Arbe's current beliefs, plans and expectations, including, without limitation, Arbe's belief that it will continue to be able to execute strongly on its business plan. Words such as "believe," "anticipate," "estimate," "expect," "project," "intend," "plan," "forecast," "goal," "could," "would," "should," "if," "may," "might," "future," "target," "trend," "seek to," "will continue," "predict," "likely," "in the event," "potential" and variations of any such words or similar expressions are indicate forward-looking statements.
Forward-looking statements are made on the basis of management's current views and assumptions and are not guarantees of future performance. Forward-looking statements are inherently subject to risks and uncertainties that could cause actual results, and actual events that occur, to differ materially from results contemplated by the forward-looking statements. These risks and uncertainties include, but are not limited to: (i) unanticipated delays or difficulties in connection with the evaluation of Arbe's products in evaluation and test programs; (ii) the success of road pilot programs for Arbe's products, (iii) Arbe's ability to develop significant revenue as a result of the test programs involving its radar system; (iv) Arbe's ability to leverage its existing relationships and secure test programs and orders resulting from the test programs; (v) Arbe's ability to meet its projected revenue level and its ability to operate profitably; (vi) Arbe's expectation that it will be engaging with Tier 1 suppliers and OEMs which would be building the radars based on its Chipset solution, eliminating expenses associated with system completion, requirement for undertaking significant capital expenditures associated with developing mass production manufacturing and the expenses of operating any such manufacturing capability; (vii) Arbe's expectation that radars are crucial to the automotive industry and will be deployed in nearly all new vehicles as a long range, cost-effective sensor with the fewest environmental limitations; (viii) Arbe's belief that the Arbe Radar Chipset heralds a breakthrough in radar technology that will enable Tier 1 manufacturers and OEMs to replace the current radars with an advanced solution that meets the safety requirements of Euro-NCAP and NHTSA for autonomous vehicles at all levels of autonomous driving; (ix) Arbe's ability to develop or have access to the latest developments relating to radar and autonomous driving vehicles; (x) Arbe's ability to have products manufactured for it by third parties that meet Arbe's and its customers quality standards and delivery requirements; (xi) Arbe's ability to attract and retain highly skilled personnel and senior management, including research and development, sales and marketing personnel; (xii) Arbe's ability to obtain funding when required through debt and equity financings; (xiii) the effect of inflation and supply chain problems on Arbe's business, including Arbe's ability to obtain semiconductor products when needed and at a reasonable price; (xiv) Arbe's ability to develop and market products based on its radar technology for uses outside of the automotive industry; (xv) accidents or bad press resulting from accidents involving autonomous driving vehicles, even those using radar products from other companies or based on other technology; and the effect of any accidents with vehicles using Arbe's radar system; (xvi) the failure of the markets for Arbe's current or new technologies and products to materialize to the extent or at the rate that Arbe expects; (xvii) unexpected delays or difficulties related to the development of Arbe's technologies and products; (xviii) the effect of laws and changes in laws that have an effect on the market for or the requirement for autonomous vehicles; (xix) the effect of COVID-19 and any new variants or any pandemics or multinational epidemics and actions taken by governments and industry to address the effects of the pandemic and the corresponding macroeconomic uncertainty; (xvii) risks related to the potential impact of new accounting standards on Arbe's financial position, results of operations or cash flows; (xx) changes or inaccuracies in market projections; (xxi) changes in Arbe's business strategy; and (xxii) the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note Regarding Forward-Looking Statements'' and the additional risks described in Arbe's prospectus dated November 2, 2021 which was filed by Arbe with the Securities and Exchange Commission on November 4, 2021, as well as the other documents filed by Arbe with the SEC. Arbe undertakes no duty to revise or update publicly any forward-looking statement for any reason, except as otherwise required by law.
CONSOLIDATED BALANCE SHEETS | ||||||||
(U.S. dollars in thousands) | ||||||||
September 30, 2021 | December 31, 2020 | |||||||
Current Assets: | (Unaudited) | (Audited) | ||||||
Cash and cash equivalents | 3,929 | 2,857 | ||||||
Restricted cash | 120 | 97 | ||||||
Short term bank deposits | - | 100 | ||||||
Trade Receivable | 365 | 137 | ||||||
Prepaid expenses and other receivables | 904 | 830 | ||||||
Total current assets | 5,318 | 4,021 | ||||||
Non-Current Asset | ||||||||
Deferred transaction costs * | 1,685 | - | ||||||
Property and equipment, net | 826 | 384 | ||||||
Total non-current assets | 2,511 | 384 | ||||||
Total assets | 7,829 | 4,405 | ||||||
Current liabilities: | ||||||||
Current maturities of long-term loan | - | 1,879 | ||||||
Short term loan | 4,780 | - | ||||||
Trade payables | 2,854 | 1,209 | ||||||
Employees and payroll accruals | 2,503 | 1,538 | ||||||
Deferred revenues | 1,012 | 281 | ||||||
Accrued expenses and other payables | 2,264 | 364 | ||||||
Total current liabilities | 13,413 | 5,271 | ||||||
Long term liabilities | ||||||||
Long-term loan | - | 676 | ||||||
Convertible loan | 30,844 | 1,641 | ||||||
Warrants to purchase Series B-1 preferred shares | 1,751 | 375 | ||||||
Warrants to purchase Series B-2 preferred shares | 1,906 | 1,159 | ||||||
Total long-term liabilities | 34,501 | 3,851 | ||||||
REDEEMABLE CONVERTIBLE PREFERRED SHARES | 61,560 | 55,440 | ||||||
SHAREHOLDERS' DEFICIENCY: | ||||||||
Ordinary Shares | *) | *) | ||||||
Additional paid-in capital | 2,154 | 1,397 | ||||||
Accumulated Deficit | (103,799) | (61,554) | ||||||
Total shareholders' deficiency | (101,645) | (60,157) | ||||||
Total liabilities, redeemable convertible preferred shares and shareholders' | 7,829 | 4,405 | ||||||
* Represents transaction costs incurred by Arbe in consummating the transaction. $1.7 million were recorded |
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
(U.S. dollars in thousands, except share and per share data) | ||||||||||||||||
3 Months | 3 Months | 9 Months | 9 Months | |||||||||||||
September 30, 2021 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
Revenues | 628 | - | 1,729 | 138 | ||||||||||||
Cost of revenues | 438 | 90 | 1,116 | 227 | ||||||||||||
Gross Profit (Loss) | 190 | (90) | 613 | (89) | ||||||||||||
Operating Expenses: | ||||||||||||||||
Research and development, net | 7,432 | 2,890 | 16,984 | 9,515 | ||||||||||||
Sales and marketing | 390 | 192 | 1,137 | 752 | ||||||||||||
General and administrative | 674 | 285 | 1,793 | 792 | ||||||||||||
Total operating expenses | 8,496 | 3,367 | 19,914 | 11,059 | ||||||||||||
Operating loss | (8,306) | (3,457) | (19,301) | (11,148) | ||||||||||||
Financial expenses (income), net | 4,980 | (126) | 22,944 | (27) | ||||||||||||
Net loss | (13,286) | (3,331) | (42,245) | (11,121) | ||||||||||||
Basic and diluted net loss per share attributable to | (1.35) | (0.36) | (4.40) | (1.21) | ||||||||||||
Weighted-average number of shares used in | 9,870,463 | 9,238,425 | 9,596,666 | 9,182,514 | ||||||||||||
* The number of ordinary shares retroactively reflects the 46.25783-for-one stock split of the ordinary shares which |
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(U.S. dollars in thousands) | ||||||||
9 Months Ended | 9 Months Ended | |||||||
September 30, 2021 | September 30, 2020 | |||||||
Cash flows from operating activities: | (Unaudited) | (Unaudited) | ||||||
Net Loss | (42,245) | (11,121 | ||||||
Adjustments to reconcile loss to net cash used in operating activities: | ||||||||
Depreciation | 246 | 255 | ||||||
Stock-based compensation | 488 | 290 | ||||||
Warrants to service providers | 56 | 43 | ||||||
Revaluation of warrants and accretion | 4,738 | 268 | ||||||
Revaluation of convertible loan | 17,866 | - | ||||||
Change in operating assets and liabilities: | ||||||||
Decrease (increase) in trade receivable | (162) | 28 | ||||||
Decrease (increase) in prepaid expenses and other receivables | (74) | (33) | ||||||
Increase (decrease) in trade payables | 1,645 | (1,400) | ||||||
Increase in employees and payroll accruals | 965 | (525) | ||||||
Increase in deferred revenue | 665 | 124 | ||||||
Increase in accrued expenses and other payables | 331 | 200 | ||||||
Net cash used in operating activities | (15,481) | (11,871) | ||||||
Cash flows from investing activities: | ||||||||
Change in bank deposits | 100 | 7,860 | ||||||
Purchase of property and equipment | (687) | (156) | ||||||
Net cash provided by (used in) investing activities | (587) | 7,704 | ||||||
Cash flows from financing activities: | ||||||||
Repayment of long-term loan | (2,639) | (1,161) | ||||||
Proceeds from short term loan | 4,733 | |||||||
Payment of deferred transaction costs | (117) | |||||||
Proceeds from issuance of redeemable convertible preferred shares and warrants | - | 1,190 | ||||||
Proceeds from exercise of warrants | 3,637 | |||||||
Proceeds from exercise of options | 212 | 30 | ||||||
Proceeds from convertible loan | 11,337 | |||||||
Net cash provided by financing activities | 17,163 | 59 | ||||||
Increase (decrease) in cash, cash equivalents and restricted cash | 1,095 | (4,108) | ||||||
Cash, cash equivalents and restricted cash at the beginning of the year | 2,954 | 7,003 | ||||||
Cash, cash equivalents and restricted cash at the end of the period | 4,049 | 2,895 |
RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS | ||||||||||||||||
(U.S. dollars in thousands, except share and per share data) | ||||||||||||||||
3 Months | 3 Months | 9 Months | 9 Months | |||||||||||||
September 30, 2021 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
GAAP net loss attributable to ordinary | (13,286) | (3,331) | (42,245) | (11,121) | ||||||||||||
Add: | ||||||||||||||||
Stock-based compensation | 176 | 83 | 488 | 290 | ||||||||||||
Warrants to service providers | 19 | 15 | 56 | 43 | ||||||||||||
Revaluation of warrants and accretion | 612 | 114 | 4,738 | 268 | ||||||||||||
Revaluation of convertible loan | 4,160 | - | 17,866 | - | ||||||||||||
Non-GAAP net loss | (8,319) | (3,119) | (19,097) | (10,520) | ||||||||||||
Basic and diluted Non-GAAP net loss per share | (0.84) | (0.34) | (1.99) | (1.15) | ||||||||||||
Weighted-average number of shares used in | 9,870,463 | 9,238,425 | 9,596,666 | 9,182,514 | ||||||||||||
* The number of ordinary shares retroactively reflects the 46.25783-for-one stock split of the ordinary shares which was effective on October 7, 2021. |
RECONCILIATION OF GAAP NET LOSS TO AJUSTED EBITDA | ||||||||||||||||
(U.S. dollars in thousands) | ||||||||||||||||
3 Months | 3 Months | 9 Months | 9 Months | |||||||||||||
September 30, 2021 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
GAAP net loss attributable to ordinary | (13,286) | (3,331) | (42,245) | (11,121) | ||||||||||||
Add: | ||||||||||||||||
Financial expenses (income), net | 4,980 | (126) | 22,944 | (27 | ||||||||||||
Depreciation & Amortization | 97 | 41 | 246 | 255 | ||||||||||||
Stock-based compensation | 176 | 83 | 488 | 290 | ||||||||||||
Warrants to service providers | 19 | 15 | 56 | 43 | ||||||||||||
Adjusted EBITDA | (8,014) | (3,318) | (18,511) | (10,560) |
Last Trade: | US$2.00 |
Daily Volume: | 90,336 |
Market Cap: | US$161.820M |
September 26, 2024 September 04, 2024 August 06, 2024 July 11, 2024 |
Leveraging its vertically-integrated approach from mine to material manufacturing, Graphite One intends to produce high-grade anode material for the lithium-ion electric vehicle battery market and energy storage systems...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS